Forbes April 3, 2025
President Donald Trump acted with restraint in his New Liberation Day tariffs when he deferred imposing tariffs on pharmaceutical products from China, India and Europe. But, so long as these tariffs are being considered, their potential threat to the pharmaceutical industry and the people it serves remains.
These are difficult times for drug discovery and manufacturing. John Crowley. CEO of the Biotechnology Innovation Organization, a trade group for companies that create, manufacture and market drugs derived from biological components, which are some of the most sophisticated and advanced drugs, was recently asked about the state of the health industry. “I don’t know if it’s broken, but it’s dangerously close,” he said, adding “these tariffs potentially could be an existential...
Today's Sponsors
Today's Sponsor